The World of Health & Medicine News

Study Finds CGMs Could Overestimate Food’s Impact on Blood Sugar Among Nondiabetic Individuals

Study Finds CGMs Could Overestimate Food’s Impact on Blood Sugar Among Nondiabetic Individuals

 CGMs may inaccurately estimate blood sugar levels in healthy individuals, leading to unnecessary dietary changes.

  • Discrepancies arise because CGMs measure glucose in interstitial fluid, not directly in blood, causing potential errors

As continuous glucose monitors (CGMs) become more widely used to help manage blood sugar levels in individuals with diabetes, findings from the University of Bath suggest that these devices may not be as accurate as commonly believed. The study authors, who published their results in The American Journal of Clinical Nutrition, noted that CGMs could be overestimating blood sugar levels in healthy adults that are using these devices to track how different foods affect their glucose levels, leading to unnecessary diet changes.

CGMs are fantastic tools for people with diabetes because even if a measurement isn’t perfectly accurate, it’s still better than not having a measurement at all. However, for someone with good glucose control, they can be misleading based on their current performance. For healthy individuals, relying on CGMs could lead to unnecessary food restrictions or poor dietary choices,” Javier Gonzalez, PhD, professor at the University of Bath, said in a news release

spot_img

Explore more

spot_img

US, European regulators set principles for ‘good AI practice’ in drug...

US, European regulators set principles for 'good AI practice' in drug development The U.S. Food and Drug Administration and the European Medicines Agency jointly issued...

8 Spices With More Anti-Inflammatory Benefits Than Turmeric

8 Spices With More Anti-Inflammatory Benefits Than Turmeric Certain spices can help reduce inflammation, a key factor in chronic conditions like diabetes and heart disease....

Sarepta’s Duchenne gene therapy slows disease progression, three-year data shows

Sarepta's Duchenne gene therapy slows disease progression, three-year data shows Sarepta Therapeutics' gene therapy for a muscle‑wasting disorder slowed disease progression and showed sustained benefit...

Lilly’s Zepbound plus Taltz boosts arthritis relief, weight loss in late-stage...

Lilly’s Zepbound plus Taltz boosts arthritis relief, weight loss in late-stage trial Eli Lilly (LLY.N), opens new tab said on Thursday a late-stage trial showed its weight-loss...

US withdraws from the World Health Organization

US withdraws from the World Health Organization The United States officially left the World Health Organization on Thursday after a year of warnings that doing...

This Popular Supplement May Help Inhibit Colorectal Cancer Development

This Popular Supplement May Help Inhibit Colorectal Cancer Development New clinical evidence indicates that a widely used supplement may alter gut microbes involved in vitamin...

Short, intensive workouts can help fight bowel cancer

Short, intensive workouts can help fight bowel cancer As many of us embark on an exercise or gym routine for the new year, research reveals...

Neuralink plans ‘high-volume’ brain implant production by 2026, Musk says

Neuralink plans 'high-volume' brain implant production by 2026, Musk says Elon Musk's brain implant company Neuralink will start "high-volume production" of brain-computer interface devices and...